The macroeconomic consequences of renouncing to universal access to antiretroviral treatment for hiv in africa: A micro-simulation model

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Ventelou, Bruno ^a,b,c   Arrighi, Yves ^a,b,c   Greener, Robert ^d   Lamontagne, Erik ^d   Carrieri, Patrizia ^a,b,c   Moatti, Jean Paul ^a,b,c  

^a AIX MARSEILLE UNIV   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c The Regional Health Observatory of Provence Alpes Cote d'Azur   (France)

^d UNAIDS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

AFRICA; AGE; ARTICLE; CAMEROON; CD4 LYMPHOCYTE COUNT; COST CONTROL; ECONOMIC ASPECT; ECONOMIC DEVELOPMENT; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH SURVEY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFORMATION PROCESSING; MEDICAL DECISION MAKING; MORTALITY; POPULATION STRUCTURE; PRACTICE GUIDELINE; PRODUCTIVITY; PUBLIC HEALTH SERVICE; SCALE UP; SIMULATION; SWAZILAND; TANZANIA; WORLD HEALTH ORGANIZATION; ADOLESCENT; ADULT; COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; MALE; MIDDLE AGED; THEORETICAL MODEL;

ADOLESCENT; ADULT; AFRICA; ANTI-RETROVIRAL AGENTS; COST-BENEFIT ANALYSIS; FEMALE; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MODELS, THEORETICAL; YOUNG ADULT;

EID: 84859701241     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034101     Document Type: Article

References (50)

1. UNAIDS, (2010) Getting to zero: UNAIDS 2011-2015 strategy. 2 Geneva Available: http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2010/JC2034_UNAIDS_Strategy_en.pdf. Accessed 2012 March.
2. UNAIDS, (2010) Global report: UNAIDS report on the global AIDS epidemic 2010. Geneva. 2 Available: http://www.unaids.org/globalreport/Global_report.htm. Accessed 2012 March.
3. WHO, UNAIDS, UNICEF, (2010) Toward universal access. Scaling up priority HIV/AIDS interventions in the health sector. Progress report 2010. 2 Geneva Available: http://www.who.int/hiv/pub/2010progressreport/report/en/index.html. Accessed 2012 March.
4. Katzenstein D, Koulla-Shiro S, Laga M, Moatti JP, (2010) Learning and doing: operational research and access to HIV treatment in Africa. AIDS 24 (Suppl 1): S1-4.
5. Walensky RP, Kuritzkes DR, (2010) The impact of the President's Emergency Plan for AIDS Relief (PEPfAR) beyond HIV and why it remains essential. Clin Infect Dis 50: 272-275.
6. Crowley S, Rollins N, Shaffer N, Guerma T, Vitoria M, et al. (2010) New WHO HIV treatment and prevention guidelines. Lancet 375: 874-875.
7. Orsi F, Carrieri MP, Coriat B, Delaporte E, Moatti JP, et al. (2010) Call for action to secure universal access to ART in developing countries. Lancet 375: 1693-1694.
8. GFATM, (2010) Funding of round 10 and timing and resource scenarios for future funding opportunities. GF/B22/18. Twenty-Second Board Meeting 2010 Dec 13-15. Sofia; Bulgaria.
9. GFATM, (2010) Report of the Executive Director. GF/ B22/3. Twenty-Second Board Meeting Dec 13-15. Sofia; Bulgaria.
10. Gostin LO, Kim SC, (2011) Ethical allocation of preexposure HIV prophylaxis. JAMA 305: 191-192.
11. Bongaarts J, Over M, (2010) Public health. Global HIV/AIDS policy in transition. Science 328: 1359-1360.
12. UNAIDS, (2010) Making sense of the money. Where does the money for AIDS go? Geneva Available: http://data.unaids.org/pub/Outlook/2010/20100713_outlook_money_en.pdf. Accessed 2012 March 2.
13. Izazola-Licea JA, Wiegelmann J, Aran C, Guthrie T, de Lay P, et al. (2009) Financing the response to HIV in low-income and middle-income countries. J Acquir Immune Defic Syndr 52 (Suppl 2): S119-126.
14. Hecht R, Stover J, Bollinger L, Muhib F, Case K, et al. (2010) Financing of HIV/AIDS programme scale-up in low-income and middle-income countries, 2009-31. Lancet 376: 1254-1260.
15. Young A, (2005) The Gift of the Dying: The Tragedy of AIDS and the Welfare of Future African Generations. The Quarterly Journal of Economics 120: 423-466.
16. Bell C, Devarajan S, Gersbach H, (2006) The Long-Run Economic Costs of aids: A Model with an Application to South Africa. The World Bank Economic Review 20: 55-89.
17. Goenka A, Liu L, (2010) Infectious diseases and endogenous fluctuations. Economic Theory pp. 1-25.
18. Ventelou B, Moatti JP, Videau Y, Kazatchkine M, (2008) 'Time is costly': modelling the macroeconomic impact of scaling-up antiretroviral treatment in sub-Saharan Africa. AIDS 22: 107-113.
19. Leclerc PM, Matthews AP, Garenne ML, (2009) Fitting the HIV epidemic in Zambia: a two-sex micro-simulation model. PLoS One 4: e5439.
20. United Nations Statistics Division (2010) National Accounts Estimates of Main Aggregates. Available: http://unstats.un.org/unsd/snaama/introduction.asp. Accessed 2012 March 2.
21. Swaziland Central Statistical Office, ORC Macro (2008) The 2006-2007 Swaziland Demographic and Health Survey; Final Report. 2 Available from: http://www.measuredhs.com/pubs/pdf/FR202/FR202.pdf. Accessed 2012 March.
22. Tanzania National Bureau of Statistics, ORC Macro, (2005) The 2004-2005 Tanzania Demographic and Health Survey; Final Report. Available from: http://www.measuredhs.com/publications/publication-AIS1-AIS-Final-Reports.cfm. Accessed 2012 March 2.
23. Institut National de la Statistique du Cameroon, ORC Macro (2005) Enquête Démographique et-de Santé Cameroon 2004. Available: http://www.measuredhs.com/pubs/pdf/FR163/FR163-CM04.pdf. Accessed 2012 March 2.
24. UNPD, (2010) World Population Prospects. Available: http://esa.un.org/unpd/wpp/unpp/panel_population.htm. Accessed 2012 March 2.
25. WHO, (2006) Antiretroviral therapy for HIV Infection in Adults and Adolescents: Recommendations for a Public Health Approach. 2006 Revision. Geneva Available: http://www.who.int/hiv/pub/guidelines/artadultguidelines.pdf. Accessed 2012 March 2.
26. WHO, (2010) Antiretroviral therapy for HIV Infection in Adults and Adolescents: Towards Universal Access. Recommendations for a Public Health Approach. 2010 Revision. Geneva. Available: http://whqlibdoc.who.int/publications/2010/9789241599801_eng.pdf. Accessed 2012 March 2.
27. UNAIDS, (2009) Cost estimates. AIDS Financing and Economics. Geneva. Available: http://www.who.int/hiv/topics/treatment/ART_cost_estimates.pdf. Accessed 2012 March 2.
28. Granich RM, Gilks CF, Dye C, de Cock KM, Williams BG, (2009) Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 373: 48-57.
29. Fox MP, Rosen S, MacLeod WB, Wasunna M, Bii M, et al. (2004) The impact of HIV/AIDS on labour productivity in Kenya. Tropical Medicine & International Health 9: 318-324.
30. Habyarimana J, Mbakile B, Pop-Eleches C, (2010) The Impact of HIV/AIDS and ARV Treatment on Worker Absenteeism. Journal of Human Resources 45: 809-839.
31. Thirumurthy H, Zivin JG, Goldstein M, (2008) The Economic Impact of AIDS Treatment. Journal of Human Resources 43: 511-552.
32. Kyereh K, Hoffman D, (2008) The Impact of HIV/AIDS on Skills availability in South African Coal Mines. 5th Post Graduate Conference on Construction Industry Development. Bloemfontein, South Africa.
33. UNITAID, (2009) New Prices Reductions for key drugs. Geneva. Available: http://www.unitaid.eu/fr/20090417198/ACTUALITES/UNITAID-and-the-Clinton-HIV/AIDS-Initiative-Announce-New-Price-Reductions-for-key-drugs.html. Accessed 2012 March 2.
34. Stover J, Bollinger L, Avila C, (2011) Estimating the Impact and Cost of the WHO 2010 Recommendations for Antiretroviral Therapy. AIDS Res Treat 2011 738271.
35. Stover J, Korenromp EL, Blakley M, Komatsu R, Viisainen K, et al. (2011) Long-Term Costs and Health Impact of Continued Global Fund Support for Antiretroviral Therapy. PLoS One 6: e21048.
36. Dongmo Nguimfack B, (2010) Transaction prices for Antiretroviral Medicines and HIV Diagnostics from 2008 to October 2010. Geneva: WHO.Global Price Reporting Mechanism. Available: http://www.who.int/hiv/pub/amds/gprm_summary_report_dec2010.pdf. Accessed 2012 March 2.
37. Over M, Marseille E, Sudhakar K, Gold J, Gupta I, et al. (2006) Antiretroviral therapy and HIV prevention in India: modeling costs and consequences of policy options. Sex Transm Dis 33: S145-152.
38. Cleary SM, McIntyre D, Boulle AM, (2006) The cost-effectiveness of antiretroviral treatment in Khayelitsha, South Africa-a primary data analysis. Cost Eff Resour Alloc 4: 20.
39. Badri M, Cleary S, Maartens G, Pitt J, Bekker LG, et al. (2006) When to initiate highly active antiretroviral therapy in sub-Saharan Africa? A South African cost-effectiveness study. Antivir Ther 11: 63-72.
40. Bachmann MO, (2006) Effectiveness and cost effectiveness of early and late prevention of HIV/AIDS progression with antiretrovirals or antibiotics in Southern African adults. AIDS Care 18: 109-120.
41. Bendavid E, Grant P, Talbot A, Owens DK, Zolopa A, (2011) Cost-effectiveness of antiretroviral regimens in the World Health Organization's treatment guidelines: a South African analysis. AIDS 25: 211-220.
42. Moatti JP, Marlink R, Luchini S, Kazatchkine M, (2008) Universal access to HIV treatment in developing countries: going beyond the misinterpretations of the 'cost-effectiveness' algorithm. AIDS 22 (Suppl 1): S59-66.
43. Resch S, Korenromp E, Stover J, Blakley M, Krubiner C, et al. (2011) Economic Returns to Investment in AIDS Treatment in Low and Middle Income Countries. PLoS One 6: e25310.
44. Walensky RP, Wood R, Ciaranello AL, Paltiel AD, Lorenzana SB, et al. (2010) Scaling up the 2010 World Health Organization HIV Treatment Guidelines in resource-limited settings: a model-based analysis. PLoS Med 7: e1000382.
45. El-Sadr WM, Affrunti M, Gamble T, Zerbe A, (2010) Antiretroviral therapy: a promising HIV prevention strategy? J Acquir Immune Defic Syndr 55 (Suppl 2): S116-121.
46. Dabis F, Newell ML, Hirschel B, (2010) HIV drugs for treatment, and for prevention. Lancet 375: 2056-2057.
47. OECD, (2010) Aid Statistics. Available: http://www.oecd.org/dac/stats/data. Accessed 2012 March 2.
48. Samb B, Evans T, Dybul M, Atun R, Moatti JP, et al. (2009) An assessment of interactions between global health initiatives and country health systems. Lancet 373: 2137-2169.
49. Bennett S, Ozawa S, Rao KD, (2010) Which path to universal health coverage? Perspectives on the World Health Report 2010. PLoS Med 7: e1001001.
50. USAID, (2010) Using HAPSAT for HIV Program Sustainability Analysis: an Introductory Guide. Health Systems 2020. United States Agency of International Development 2010.